| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Feb―24 |
COVID-19 modeling based on real geographic and population data |
EMİR BAYSAZAN, AHMET NİHAT BERKER, HASAN MANDAL, HAKAN KAYGUSUZ |
| 2 |
[GO] |
2022―Dec―23 |
COVID-19 in pediatric nephrology centers in Turkey |
EMRE LEVENTOĞLU, YEŞİM ÖZDEMİR ATİKEL, HÜLYA NALÇACIOĞLU, İSMAİL DURSUN, HASAN DURSUN, ZEYNEP NAGEHAN YÜRÜK YILDIRIM, et al. (+9) NURDAN YILDIZ, GÜLŞAH KAYA AKSOY, MEHMET TAŞDEMİR, MEHTAP ÇELAKIL, BELTİNGE DEMİRCİOĞLU KILIÇ, ŞENAY ZIRHLI SELÇUK, NUR CANPOLAT, EVRİM KARGIN ÇAKICI, SARE GÜLFEM ÖZLÜ |
| 3 |
[GO] |
2022―Dec―23 |
A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection |
MEVLÜT TAMER DİNCER, NECMİ EREN, AHMET MURT, NURİYE YILDIZ, ŞEYDA GÜL ÖZCAN, METİN ERGÜL, et al. (+6) SİBEL GÖKÇAY BEK, ZEYNEP ATLI, SİNAN TRABULUS, ERKAN DERVİŞOĞLU, HAMDİ LEVENT DOĞANAY, NURHAN SEYAHİ |
| 4 |
[GO] |
2022―Dec―23 |
Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination |
SERKAN İŞGÖREN, GİZEM KÖROĞLU, GÖZDE DAĞLIÖZ GÖRÜR, HAKAN DEMİR |
| 5 |
[GO] |
2022―Oct―21 |
The effect of frailty on the development of acute kidney injury in critically-ill geriatric patients with COVID-19 |
MURAT KÜÇÜK, BİŞAR ERGÜN, MEHMET NURİ YAKAR, ÖZER URAL ÇAKICI, ERDEM YAKA, BİLGİN CÖMERT, et al. (+2) ALİ NECATİ GÖKMEN, BEGÜM ERGAN |
| 6 |
[GO] |
2022―Oct―21 |
Brain hypoxia caused by respiratory obstruction which should not be forgotten in COVID-19 disease |
ALEKSANDR URAKOV, NIKITA MUHUTDINOV, ILNUR YAGUDIN, DARYA SUNTSOVA, MILENA SVETOVA |
| 7 |
[GO] |
2022―Oct―21 |
Magnetic resonance imaging findings in COVID-19-related anosmia |
HÜSEYİN ÇETİN, AYŞE ŞULE ATEŞ, OGÜN TAYDAŞ, BAHRİ ELMAS, ERTUĞRUL GÜÇLÜ |
| 8 |
[GO] |
2022―Oct―21 |
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study |
ORHAN KÜÇÜKŞAHİN, ABDULSAMET ERDEN, ÖZLEM KARAKAŞ, SERDAR CAN GÜVEN, BERKAN ARMAĞAN, ENES SEYDA ŞAHİNER, et al. (+9) OSMAN İNAN, ALİ CAN KURTİPEK, EMİN GEMCİOĞLU, SELMA KARAAHMETOĞLU, SEMA TURAN, SEVAL İZDEŞ, DENİZ ERDEM, ADALET AYPAK, MÜGE AYHAN |
| 9 |
[GO] |
2022―Aug―15 |
Remdesivir treatment for patients with moderate to severe COVID-19 |
İMRAN HASANOĞLU, HATİCE RAHMET GÜNER, İLHAMİ ÇELİK, FİKRET KANAT, AYŞE BATIREL, GÜLÇİN TELLİ DİZMAN, et al. (+9) ESMA ERYILMAZ EREN, DİLEK YILDIZ SEVGİ, İLKAY BOZKURT, KADRİYE KART YAŞAR, SEVTAP ŞENOĞLU, ESRA KAZAK, RIDVAN KARAALİ, AYSEL KOCAGÜL ÇELİKBAŞ, HÜSNÜ PULLUKÇU |
| 10 |
[GO] |
2022―Aug―15 |
The role of CD8+ regulatory T cells and B cell subsets in patients with COVID-19 |
HÜLYA UÇARYILMAZ, DİLEK ERGÜN, HÜSAMETTİN VATANSEV, HANDE KÖKSAL, ONUR URAL, UĞUR ARSLAN, HASİBE ARTAÇ |
| 11 |
[GO] |
2022―Aug―15 |
COVID-19 course in granulomatosis with polyangiitis: single center experience with review of the literature |
BERKAN ARMAĞAN, MEHMET AKİF EKSİN, SERDAR CAN GÜVEN, BAHAR ÖZDEMİR, PINAR AKYÜZ DAĞLI, ORHAN KÜÇÜKŞAHİN, et al. (+2) AHMET OMMA, ABDULSAMET ERDEN |
| 12 |
[GO] |
2022―Aug―15 |
Cross-sectional study of Middle East respiratory syndrome coronavirus in humans and dromedary camels in Diyala, Iraq |
ABDULRAZAK HASAN, KAREEM ALI, MOHAMMAD SALEH |
| 13 |
[GO] |
2022―Aug―15 |
Future pandemics: how can we be ready? |
ZEYNEP TÜRE YÜCE, EMİNE ALP MEŞE |
| 14 |
[GO] |
2022―Jul―08 |
Return visit characteristics of SARS-CoV-2 PCR-positive cases in a pediatric emergency department |
NİHAN ŞIK, DURGÜL ÖZDEMİR, MURAT DUMAN |
| 15 |
[GO] |
2022―Jul―08 |
Risk factors and prognosis in children hospitalized due to pandemic H1N1 influenza A virus infection in Ankara, Turkey* |
MEDİNE AYŞİN TAŞAR, YILDIZ BİLGE, ÖZGE UYSAL SOYER, ŞÜKRAN YILDIRIM, MUSTAFA TAŞAR, FATMA İNCİ ARIKAN |
| 16 |
[GO] |
2022―Jul―08 |
Chest radiography and computed tomography findings of cases with pandemic influenza A (H1N1/09) infection |
PINAR NERCİS KOŞAR, ZELİHA KOÇAK TUFAN, ELİF ERGÜN, HASAN YİĞİT, UĞUR KOŞAR, ALİ PEKCAN DEMİRÖZ |
| 17 |
[GO] |
2022―Jun―22 |
The clinical follow-up and management of COVID-19 in children and adolescents withan immunocompromised state or a malignancy |
İREM CEREN ERBAŞ, HATİCE KARAOĞLU ASRAK, AYŞE ÇAKIL GÜZİN, ŞİLEM ÖZDEM ALATAŞ, ŞEFİKA AKYOL, MERAL TORUN BAYRAM, et al. (+4) REFİK EMRE ÇEÇEN, DİLEK İNCE, ÖZLEM TÜFEKÇİ, NURŞEN BELET |
| 18 |
[GO] |
2022―Jun―22 |
Turkey's transition to face-to-face schooling during the COVID-19 pandemic |
MAHMUT ÖZER, HAYRİ EREN SUNA, MATJAZ PERC, SADRİ ŞENSOY, SEVİL UYGUN İLİKHAN |
| 19 |
[GO] |
2022―Jun―22 |
The effect of COVID-19 pandemic in a large series of patients with Takayasu arteritis |
ALİ KARAKAŞ, TUBA YÜCE İNEL, FATOŞ ÖNEN, İSMAİL SARI |
| 20 |
[GO] |
2022―Jun―22 |
Determination of COVID-19 PCR positivity and mutation status in coronaVacvaccinated individuals in Turkey |
AHMET ÇALIŞKAN, MÜCAHİT SEÇME, İLKNUR KALELİ, TUĞBA SARI, SEDEF ZELİHA ÖNER, SANİYE KÜÇÜKAKIN YAKA, BÜŞRA DÖNMEZ |
| 21 |
[GO] |
2022―Jun―22 |
An evaluation of the results of convalescent plasma therapy applied to pregnant womendiagnosed as COVID-19- positive in a pandemic center: A prospective cohort study |
SEYİT AHMET EROL, ATAKAN TANAÇAN, HAKAN APAYDIN, ŞULE GÖNCÜ AYHAN, DENİZ OLUKLU, DERYA UYAN HENDEM, et al. (+7) SERPİL ÜNLÜ, ABDULSAMET ERDEN, ÖZLEM MORALOĞLU TEKİN, AHMET OMMA, İHSAN ATEŞ, ORHAN KÜÇÜKŞAHİN, DİLEK ŞAHİN |
| 22 |
[GO] |
2022―Jun―22 |
The efficacy of anakinra compared to standard care of treatment for COVID-19: a metaanalysis |
HAMNA MALIK, HIRA BINT ABDUL JABBAR, FARAH LATIF, AZZA SARFRAZ, ZOUINA SARFRAZ, MUZNA SARFRAZ |
| 23 |
[GO] |
2022―May―19 |
Evaluation of the frequency and intensity of COVID-19 in patients with ankylosingspondylitis under anti-TNF therapy |
SÜMEYYE MERVE TÜRK, ZEYNEP ÖZTÜRK, DAMLA KARATAŞ, ÜNAL ERKORKMAZ, EMEL GÖNÜLLÜ |
| 24 |
[GO] |
2021―Dec―18 |
From asymptomatic to critical illness: decoding various clinical stages of COVID-19 |
İlhami ÇELİK, Recep ÖZTÜRK |
| 25 |
[GO] |
2021―Dec―18 |
Achievements of the COVID-19 Turkey Platform in vaccine and drug development with an approach of “co-creation and s쳮ding together” |
Hasan MANDAL |
| 26 |
[GO] |
2021―Nov―30 |
Immune dysfunction in COVID-19 and judicious use of anti-rheumatic drugs for the treatment of hyperinflammation |
|
| 27 |
[GO] |
2021―Nov―30 |
Epidemiology of COVID-19: What Changed in One Year? |
|
| 28 |
[GO] |
2021―Nov―12 |
EVALUATION OF THE FREQUENCY and INTENSITY OF COVID-19 IN PATIENTS WITH ANKYLOSING SPONDYLITIS UNDER ANTI-TNF THERAPY |
|
| 29 |
[GO] |
2021―Nov―12 |
Effect of Tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospecitve cohort study |
|
| 30 |
[GO] |
2021―Nov―04 |
Evaluation of Coagulation with TEG in Patients Diagnosed COVID-19 |
|
| 31 |
[GO] |
2021―Oct―19 |
SARS-COV-2 vaccine: First-month results of a six-month follow-up study |
|
| 32 |
[GO] |
2021―Oct―06 |
Magnetic Resonance Imaging Findings in COVID-19-related Anosmia: Initial Results |
|
| 33 |
[GO] |
2021―Sep―30 |
Non-pharmaceutical interventions in Turkey and worldwide during COVID-19 pandemic |
|
| 34 |
[GO] |
2021―Sep―30 |
COVID-19 and SEPSIS |
|
| 35 |
[GO] |
2021―Sep―19 |
Pregnancy and COVID-19: Prevention, Vaccination, Therapy and Beyond |
|
| 36 |
[GO] |
2021―Sep―08 |
A COVID-19 First Evaluation Clinic at a University Hospital in Turkey |
|
| 37 |
[GO] |
2021―Sep―08 |
Decrease of left ventricular ejection fraction in severe illness patients due to COVID-19 may improve as the disease resolves |
|
| 38 |
[GO] |
2021―Aug―29 |
Correlation of neuroimaging and thorax CT findings in patients with COVID-19: a large single-center experience |
|
| 39 |
[GO] |
2021―Aug―29 |
Clinical Characteristics and Risk Factors for 28-day Mortality in Critically Ill Patients with COVID-19: A Retrospective Cohort Study |
|
| 40 |
[GO] |
2021―Aug―27 |
From Asymptomatic to Critical Illness: Decoding Various Clinical Stages of COVID-19 |
|
| 41 |
[GO] |
2021―Aug―21 |
Retrospective Evaluation of Seven Different Treatment Protocols in Hospitalized COVID-19 Patients |
|
| 42 |
[GO] |
2021―Aug―16 |
From asymptomatic to critical illness different clinical manifestations of COVID-19 in Children |
|
| 43 |
[GO] |
2021―Aug―16 |
Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients |
|
| 44 |
[GO] |
2021―Aug―15 |
Evaluating the efficiency of public policy measures against COVID-19 |
|
| 45 |
[GO] |
2021―Aug―15 |
Antiviral treatment of COVID-19: An update |
|
| 46 |
[GO] |
2021―Aug―09 |
THE RADIOLOGICAL FINDINGS OF COVID-19 |
|
| 47 |
[GO] |
2021―Aug―09 |
Short-Term Economic Impact of the Covid-19 Pandemic on the Global and Turkish Economy |
|
| 48 |
[GO] |
2021―Aug―09 |
Turkey?s Response to COVID-19 Pandemic: Strategy and Key Actions |
|
| 49 |
[GO] |
2021―Aug―09 |
RNA-Based COVID-19 Vaccine Candidates with Clinical Phase Trials in Progress |
|
| 50 |
[GO] |
2021―Aug―09 |
GLOBAL HEALTH EMERGENCIES DURING THE PANDEMIC AND THEIR SOLUTIONS |
|
| 51 |
[GO] |
2021―Aug―04 |
Comparison of SARS-COV2 antibody assays in PCR negative and PCR positive Turkish patients |
|
| 52 |
[GO] |
2021―Aug―02 |
Assessment of olfactory and gustatory functions in COVID-19 patients |
|
| 53 |
[GO] |
2021―Aug―02 |
Implementation of post-intensive care outpatient clinic (I-POINT)
for critically-ill COVID-19 survivors |
|
| 54 |
[GO] |
2021―Aug―02 |
ALLERGIC REACTIONS AGAINST COVID-19 VACCINES |
|
| 55 |
[GO] |
2021―Jul―22 |
Current Infection Prevention and Control Strategies of COVID-19 in Hospitals |
|
| 56 |
[GO] |
2021―Jul―21 |
Managing life during the pandemic: Communication strategies, mental health and the ultimate toll of the COVID-19 |
|
| 57 |
[GO] |
2021―Jul―21 |
One and a half years into the COVID-19 pandemic - Exit strategies and efficacy of SARS-CoV-2 vaccines for holistic management and achieving global control |
|
| 58 |
[GO] |
2021―Jul―21 |
How efficient are facial masks against COVID-19? Evaluating the mask use of various communities one year into the pandemic |
|
| 59 |
[GO] |
2021―Jul―21 |
Pandemic Hospitals and Re-organizing Emergency Departments |
|
| 60 |
[GO] |
2021―Jul―07 |
Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity |
|
| 61 |
[GO] |
2021―Jun―27 |
Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients |
|
| 62 |
[GO] |
2021―Jun―23 |
Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19 |
|
| 63 |
[GO] |
2021―Jun―13 |
Effect of Coronavirus Pandemic on Organ Donation and Transplantation in Turkey |
|
| 64 |
[GO] |
2021―Jun―10 |
Long-term proton pump inhibitor use is a risk factor for
mortality in patients hospitalized for COVID-19 |
|
| 65 |
[GO] |
2021―Jun―07 |
COVID-19 third wave: A challenge for overburdened and shabby healthcare system of Pakistan |
|
| 66 |
[GO] |
2021―May―23 |
Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis |
|
| 67 |
[GO] |
2021―May―19 |
Galectin-3: Can It Be A Diagnostic Tool For Pneumonia In COVID-19 Patients? |
|
| 68 |
[GO] |
2021―May―07 |
Covid-19 Clinical Course and Blood Groups: Turkish Population-Based Study |
|
| 69 |
[GO] |
2021―May―07 |
Risk Factors Associated with Mortality in Intensive Care COVID-19 Patients: the importance of chest CT score and intubation timing as risk factors |
|
| 70 |
[GO] |
2021―Apr―30 |
First known COVID-19 case and contact tracing efforts in
Istanbul, Turkey |
|
| 71 |
[GO] |
2021―Apr―23 |
Pleural complications of Covid-19 pneumonia |
|
| 72 |
[GO] |
2021―Apr―21 |
Pulse Steroid Treatment for Hospitalized Adults with COVID-19 |
|
| 73 |
[GO] |
2021―Apr―21 |
The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients |
|
| 74 |
[GO] |
2021―Apr―16 |
A single center survey study of systemic vasculitis and COVID-19 during the first months of pandemic |
|
| 75 |
[GO] |
2021―Apr―12 |
Impact of COVID-19 on serum melatonin levels and sleep parameters in children |
|
| 76 |
[GO] |
2021―Mar―28 |
Effects of the COVID-19 Pandemic on Psychology and Disease Activity in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis |
|
| 77 |
[GO] |
2021―Mar―17 |
Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department? |
|
| 78 |
[GO] |
2021―Mar―15 |
The Comparison of Lopinavir/Ritonavir Combination and Favipiravir In COVID-19 Treatment |
|
| 79 |
[GO] |
2021―Mar―11 |
Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic |
|
| 80 |
[GO] |
2021―Mar―08 |
The Relationship of Extent of Initial Radiological Involvement with the Need of Intensive Care, Mortality Rates and Laboratory Parameters in COVID-19. |
|
| 81 |
[GO] |
2021―Mar―08 |
CURRENT COMMUNITY TRANSMISSION AND FUTURE PERSPECTIVES ON THE COVID-19 PROCESS |
|
| 82 |
[GO] |
2021―Mar―01 |
An evaluation of chest computed tomography and hemogram data in patients with COVID-19: The importance of the thymus |
|
| 83 |
[GO] |
2021―Feb―22 |
Impact of Hospital-acquired Acute Kidney Injury on Covid-19 Outcomes in Patients with and without Chronic Kidney Disease: A multicentre, retrospective cohort study |
|
| 84 |
[GO] |
2021―Feb―22 |
Preferences of Inflammatory Arthritis Patients for Biological Disease-Modifying Antirheumatic Drugs in the First 100 Days of COVID-19 Pandemic |
|
| 85 |
[GO] |
2021―Feb―14 |
SARS-CoV-2 associated rhabdomyolysis in 32 patients |
|
| 86 |
[GO] |
2021―Feb―01 |
How Safe Are Children With Covid-19 From Cardiac Risks? Pediatric Risk Assessment, insights from Echocardiography and Electrocardiography |
|
| 87 |
[GO] |
2021―Jan―12 |
The clinical impact of the COVID-19 pandemic on daily urological practice: First 3 month multicenter results from Istanbul |
|
| 88 |
[GO] |
2021―Jan―10 |
Evaluation of Systemic Involvement of Coronavirus Disease 2019 through Spleen; Size and Texture Analysis |
|
| 89 |
[GO] |
2020―Dec―22 |
Consensus Recommendations for Botulinum Toxin Injections
in the Spasticity Management of Children with Cerebral Palsy During COVID-19 Outbreak |
|
| 90 |
[GO] |
2020―Dec―14 |
Factors affecting mortality in geriatric patients hospitalized with COVID-19 |
|
| 91 |
[GO] |
2020―Dec―14 |
Influence of aluminum salts on COVID-19 infected patients |
Ali DEMİR, İbrahim ERAYMAN, Oğuz DOĞAN, Murat KEKİLLİ |
| 92 |
[GO] |
2020―Dec―14 |
The predictive and diagnostic accuracy of long Pentraxin-3 in COVID-19 Pneumonia |
|
| 93 |
[GO] |
2020―Dec―14 |
Evaluation of Initial Chest CT Findings of COVID-19 Pneumonia in 117 Deceased Patients: a Retrospective Study |
|
| 94 |
[GO] |
2020―Dec―11 |
A SENSITIVE INDICATOR FOR THE SEVERITY OF COVID-19: THIOL |
|
| 95 |
[GO] |
2020―Nov―27 |
Tocilizumab and COVID-19: A Meta-Analysis of 2120 Patients with Severe Disease and Implications for Clinical Trial Methodologies |
|
| 96 |
[GO] |
2020―Nov―25 |
Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey |
|
| 97 |
[GO] |
2020―Nov―16 |
THE IMPORTANCE OF QUALITY AND ACCREDITATION IN HEALTH CARE SERVICES IN THE PROCESS OF STRUGGLE AGAINST COVID-19 |
|
| 98 |
[GO] |
2020―Nov―13 |
Clinical course of COVID-19 disease in immunosuppressed renal transplant patients |
|
| 99 |
[GO] |
2020―Nov―13 |
Characteristics and Outcomes of Critically Ill Patients with Covid-19 in Sakarya, Turkey: A Single Center Cohort Study |
|
| 100 |
[GO] |
2020―Oct―29 |
Pre-emptive Action Saves Lives in A Pandemic: Closing the Grand Bazaar Before The Fire Of COVID-19 Infection Starts |
|
| 101 |
[GO] |
2020―Oct―20 |
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma |
|
| 102 |
[GO] |
2020―Oct―06 |
Cerebral hemodynamic alterations in patients with Covid-19 |
|
| 103 |
[GO] |
2020―Oct―06 |
COVID-19 transmission sources, management, and scientific research in Turkey |
|
| 104 |
[GO] |
2020―Oct―02 |
Do initial hematologic indices predict the severity of COVID-19 patients? |
|
| 105 |
[GO] |
2020―Sep―20 |
Efficacy of convalescent plasma according to blood groups in COVID-19 patients. |
|
| 106 |
[GO] |
2020―Sep―20 |
Characteristics and Mortality Determinants of COVID-19 Patients Undergoing Haemodialysis |
|
| 107 |
[GO] |
2020―Aug―25 |
The impact of the "low molecular weight heparin" administration on the clinical course of COVID-19 disease |
|
| 108 |
[GO] |
2020―Aug―11 |
COVID-19 related anxiety in people living with HIV: An online cross-sectional study |
|
| 109 |
[GO] |
2020―Aug―11 |
Melatonin, Aging and COVID-19: Could melatonin be beneficial for COVID-19 treatment in elderly? |
|
| 110 |
[GO] |
2020―Jul―28 |
Perspectives for the immune plasma treatment of COVID-19 |
|
| 111 |
[GO] |
2020―Jul―28 |
Hepatitis A susceptibility parallels high COVID-19 mortality |
|
| 112 |
[GO] |
2020―Jul―28 |
Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU |
|
| 113 |
[GO] |
2020―Jul―19 |
COVID-19 experience of the major pandemic response center in the capital: Results of the pandemic's first month in Turkey |
|
| 114 |
[GO] |
2020―Jul―19 |
The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data |
|
| 115 |
[GO] |
2020―Jun―30 |
COVID-19 and dermatology |
|
| 116 |
[GO] |
2020―Jun―30 |
The factors predicting pneumonia in COVID-19 patients: preliminary results of a university hospital in Turkey |
|
| 117 |
[GO] |
2020―Jun―12 |
Projecting the Course of COVID-19 in Turkey: A Probabilistic Modeling Approach |
|
| 118 |
[GO] |
2020―Jun―09 |
COVID-19: Pathogenesis, genetic polymorphism, flinical features and laboratory findings |
|
| 119 |
[GO] |
2020―Jun―04 |
The effects of blood group types on the risk of COVID-19 infection and its clinical outcome |
|
| 120 |
[GO] |
2020―May―31 |
Letter to the Editor: Radiological approaches to COVID-19 pneumonia |
|
| 121 |
[GO] |
2020―May―31 |
Response to letter to the editor:
radiological approaches to COVID-19 pneumonia |
|
| 122 |
[GO] |
2020―May―31 |
Characteristics of the initial patients hospitalized for COVID-19: a single-center report |
|
| 123 |
[GO] |
2020―May―18 |
Is there relationship between SARS-CoV 2 and the complement C3 and C4? |
|
| 124 |
[GO] |
2020―May―12 |
Chest CT features of the novel coronavirus disease (COVID-19) |
|
| 125 |
[GO] |
2020―Apr―30 |
The usual course of thorax CT findings of Covid-19 infection and
when should control thorax CT scan? |
|
| 126 |
[GO] |
2020―Apr―30 |
Gynecological laparoscopic surgery in the shade of COVID-19 pandemic |
|
| 127 |
[GO] |
2020―Apr―18 |
Novel coronavirus disease (COVID-19) in children |
Hasan TEZER, Tuğba BEDİR DEMİRDAĞ |
| 128 |
[GO] |
2020―Apr―18 |
COVID-19 outbreak control, example of ministry of health of Turkey |
Yasemin DEMİRBİLEK, Gülen PEHLİVANTÜRK, Zeynep Özge ÖZGÜLER, Emine ALP MEŞE |
| 129 |
[GO] |
2020―Apr―18 |
Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic |
Hasan MANDAL |
| 130 |
[GO] |
2020―Apr―18 |
Global surveillance, travel, and trade during a pandemic |
Ceren ÇETİN, Ateş KARA |
| 131 |
[GO] |
2020―Apr―17 |
Epidemiology of COVID-19 |
Cemal BULUT, Yasuyuki KATO |
| 132 |
[GO] |
2020―Apr―17 |
Protective measures for COVID-19 for healthcare providers and laboratory personnel |
Canan AĞALAR, Derya ÖZTÜRK ENGİN |
| 133 |
[GO] |
2020―Apr―17 |
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs |
Abdurrahman TUFAN, Aslıhan AVANOĞLU GÜLER, Marco MATUCCI-CERINIC |
| 134 |
[GO] |
2020―Apr―17 |
Crushing the curve, the role of national and international institutions and policy makers in COVID-19 pandemic |
Zeliha KOÇAK TUFAN, Bircan KAYAASLAN |
| 135 |
[GO] |
2020―Apr―17 |
Radiological approaches to COVID-19 pneumonia |
Şule AKÇAY, Tevfik ÖZLÜ, Aydın YILMAZ |
| 136 |
[GO] |
2020―Apr―17 |
Understanding dynamics of pandemics |
Levent AKIN, Mustafa Gökhan GÖZEL |
| 137 |
[GO] |
2020―Apr―15 |
Antiviral treatment of COVID-19 |
|
| 138 |
[GO] |
2020―Apr―15 |
Emerging and reemerging respiratory viral infections up to Covid-19 |
|
| 139 |
[GO] |
2020―Apr―15 |
Critically-ill COVID-19 patient |
|
| 140 |
[GO] |
2020―Apr―15 |
COVID-19: Prevention and control measures in community |
|
| 141 |
[GO] |
2020―Apr―15 |
Coronaviruses and SARS-CoV-2 |
|
| 142 |
[GO] |
2020―Apr―14 |
The early impact of the Covid-19 pandemic on the global and Turkish economy |
|
| 143 |
[GO] |
2020―Apr―14 |
SARS-CoV-2 epidemiology and control, different scenarios for Turkey |
|
